Waldenstrom Macroglobulinemia Market Overview: Innovations & Challenges Waldenstrom Macroglobulinemia (WM) is a rare subtype of non-Hodgkin lymphoma that leads to excessive production of monoclonal immunoglobulin M (IgM) by abnormal white blood cells. This condition can result in complications such as anemia, neuropathy, and hyperviscosity syndrome. Recent advancements in research and drug development have significantly influenced the Waldenstrom Macroglobulinemia...
0 Shares
71 Views
0 Reviews